Literature DB >> 12378387

Different risk factors for peripheral vascular calcification between diabetic and non-diabetic haemodialysis patients--importance of glycaemic control.

E Ishimura1, S Okuno, K Kitatani, M Kim, T Shoji, T Nakatani, M Inaba, Y Nishizawa.   

Abstract

AIM/HYPOTHESIS: Although derangements of calcium and phosphate control have been emphasized as important risk factors for vascular calcification in non-diabetic haemodialysis patients, similar risk factors for diabetic haemodialysis patients are not known. We compared factors affecting peripheral vascular calcification between haemodialysis patients with and without diabetes.
METHODS: We examined 421 patients on maintenance haemodialysis. There were 89 patients with Type II (non-insulin-dependent) diabetes mellitus (53 men and 36 women, 62+/-10 years old) and 332 patients without diabetes (192 men and 140 women, 59+/-13 years old). Hand roentgenography was carried out, and visible vascular calcification of the hand arteries was evaluated.
RESULTS: There were 42 diabetic patients and 45 non-diabetic patients with vascular calcification. The prevalence of vascular calcification in diabetic patients (47.1%) was higher than in non-diabetic patients (13.6%) ( p<0.001). In multivariate logistic regression, the main factors affecting vascular calcification in non-diabetic patients were advanced age, longer duration of haemodialysis, increased phosphate concentrations, male gender, and lower predialysis diastolic pressure. In diabetic patients, predictors for vascular calcification were higher values of HbA(1C) and longer duration of haemodialysis. In diabetic patients, a 1% increase in HbA(1C) increased the risk of calcification by 2.1-fold (95% CI 1.282-3.575, p=0.0029). CONCLUSION/
INTERPRETATION: We have shown that poor glycaemic control, rather than calcium and phosphate concentrations, is a predictor of peripheral vascular calcification in diabetic patients on haemodialysis. This study emphasizes that glycaemic control remains critical even in diabetic patients with end-stage renal disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12378387     DOI: 10.1007/s00125-002-0920-8

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  16 in total

1.  Increased active PTH(1-84) fraction as a predictor of poor mortality in male hemodialysis patients.

Authors:  M Inaba; S Okuno; Y Imanishi; E Ishimura; T Yamakawa; S Shoji
Journal:  Osteoporos Int       Date:  2013-09-13       Impact factor: 4.507

2.  Role of fibroblast growth factor-23 in peripheral vascular calcification in non-diabetic and diabetic hemodialysis patients.

Authors:  M Inaba; S Okuno; Y Imanishi; S Yamada; A Shioi; T Yamakawa; E Ishimura; Y Nishizawa
Journal:  Osteoporos Int       Date:  2006-08-05       Impact factor: 4.507

Review 3.  Arterial Calcification in Diabetes Mellitus: Preclinical Models and Translational Implications.

Authors:  John N Stabley; Dwight A Towler
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-12-22       Impact factor: 8.311

Review 4.  Inflammation: a culprit for vascular calcification in atherosclerosis and diabetes.

Authors:  L Bessueille; D Magne
Journal:  Cell Mol Life Sci       Date:  2015-03-08       Impact factor: 9.261

5.  Phosphatonins: physiological role and pathological changes.

Authors:  Loredana Cavalli; Celestina Mazzotta; Maria Luisa Brandi
Journal:  Clin Cases Miner Bone Metab       Date:  2012-05-29

6.  Plasma levels of fibroblast growth factor-23 and mineral metabolism in diabetic and non-diabetic patients on chronic hemodialysis.

Authors:  Fumiko Kojima; Keiko Uchida; Tetsuya Ogawa; Yoshiko Tanaka; Kosaku Nitta
Journal:  Int Urol Nephrol       Date:  2008-09-13       Impact factor: 2.370

Review 7.  Vascular ossification-calcification in metabolic syndrome, type 2 diabetes mellitus, chronic kidney disease, and calciphylaxis-calcific uremic arteriolopathy: the emerging role of sodium thiosulfate.

Authors:  Melvin R Hayden; Suresh C Tyagi; Lisa Kolb; James R Sowers; Ramesh Khanna
Journal:  Cardiovasc Diabetol       Date:  2005-03-18       Impact factor: 9.951

8.  Coronary artery calcifications predict long term cardiovascular events in non diabetic Caucasian hemodialysis patients.

Authors:  Annalisa Noce; Maria Paola Canale; Ambrogio Capria; Valentina Rovella; Manfredi Tesauro; Giorgio Splendiani; Margherita Annicchiarico-Petruzzelli; Micol Manzuoli; Giovanni Simonetti; Nicola Di Daniele
Journal:  Aging (Albany NY)       Date:  2015-04       Impact factor: 5.682

9.  AMPKα1: SUMO Wrestling Runx2 as a Strategy to Inhibit Arteriosclerotic Calcification.

Authors:  Dwight A Towler
Journal:  Circ Res       Date:  2016-07-22       Impact factor: 17.367

10.  Is abdominal aortic calcification score a cost-effective screening tool to predict atherosclerotic carotid plaque and cardiac valvular calcification in patients with end-stage renal disease?

Authors:  G P S Shantha; A A Kumar; A Mancha; M Christopher; R Koshi; G Abraham
Journal:  Indian J Nephrol       Date:  2012-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.